Great forgotten neurodegenerative diseases, Parkinson’s disease receives no National Plan unlike Alzheimer’s disease in particular. This results in a lack of coordination in the management and research, to the detriment of patients and their families.
One year after the White Paper on Parkinson’s disease , which offered twenty measures to improve the management of patients at the time of diagnosis, help them cope with their disease and boost research, progress is stalled almost. The Association France Parkinson calls the government.
Parkinson, the great “forgotten” neurodegenerative diseases
On the eve of the World Parkinson’s Day, April 11, the Association Parkinson calls on the State to launch urgently a national Parkinson Plan, like those that exist for other diseases, particularly for the Alzheimer disease . If the association has decided to act, it is estimated that Parkinson’s disease , which in France each year 14,000 new victims, is “the most overlooked of neurodegenerative diseases . ” “Today, solutions and concrete paths exist in support, but lack of resources, they are not coordinated nationally. There is no coverage of the French territory known visible and dynamic,” laments the association. Continue reading “A Parkinson when a Plan?”